An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis
Clinical trial NCT01462318 · COMPLETED
Trial details
- NCT number
- NCT01462318
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2016-01-01
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.